Show results for
Refine by
Metastasis Suppliers Serving Lesotho
25 companies found
based inTehran, IRAN
Pars Isotope Co is a prominent supplier and producer of radioisotopes in Iran, catering widely to the medical and industrial sectors. As the sole provider in the region, the company focuses on radiopharmaceuticals used for both the diagnosis and ...
The binding of this radiopharmaceutical to PSMA receptors enables effective delivery of radionuclide therapy directly to both the primary cancer cells and its metastasis. This approach aims to reduce tumor sizes and cancer cell ...
based inAnyang-si, SOUTH KOREA
Vieworks leads the innovation of imaging technologies together with talented individuals who are passionate, creative, and ethical. The company name, Vieworks, combined the words “View” and “Works,” which represents the company’s will to contribute ...
Premium Preclinical in vivo Fluorescent & Bioluminescent Imaging and Analysis System ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid tumors, significant ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
MDxHealth’s technology platform is called methylation-specific PCR (MSP), which is a proprietary DNA-based technology that functions on standard commercial PCR equipment. MSP is extremely powerful and accurate with the ability to detect a ...
based inNotting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
INOVIQ has the exclusive worldwide license for SubB2M - an engineered protein that binds to a unique sugar molecule called Neu5Gc which is only present in human cancers. In initial clinical studies, SubB2M has detected cancers with 100% sensitivity ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inGolestan Town, IRAN
Pishtaz Teb Zaman Diagnostics, started its research, development, and marketing activities in 1998, and rapidly grew to be an international brand specialized in 'In-Vitro Diagnostics Medical Devices and Clinical research'. Our range of products are ...
Carcinoembroyonic antigen (CEA) is a 150300 kD glycoprotein molecule which has been found by Gold and Freedman at 1965 and it is also known as major component of CEA glycoprotein family. This family consists of 36 different glycoproteins with the ...
based inSan Diego, CALIFORNIA (USA)
Decipher, a part of Veracyte, offers genomic tests for urologic cancers. Decipher Biosciences offers a portfolio of genomic tests, continues to build the GRID database of over 70,000 whole transcriptome profiles, and is partnering with ...
Using Decipher genomic testing to determine where a patient is within the spectrum of risk empowers you in personalizing patient ...
based inGuro-gu, SOUTH KOREA
We provide diagnostic solutions throughout the cancer treatment cycle from early cancer diagnosis to prognostic and companion diagnostics as well as postoperative monitoring. Diagnose cancer as early as possible, when the disease is easiest to ...
CTCs(Circulating Tumor Cells) are cancer cells found in blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. Geno ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inBerlin, GERMANY
WOM is an exceptional company. We are a hidden champion in the truest sense of the word. At home in the field of Minimally Invasive Medicine, we develop devices and accessories so that doctors can operate with small cuts. We produce Cameras, ...
Minimally invasive procedures have become the gold standard worldwide for many indications. Trocars are inserted into the body through small, up to one centimeter long incisions. The surgical teams insert an endoscope and special surgical ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA ...
based inBoston, MASSACHUSETTS (USA)
We can create human tissues and organs using cells from our own bodies, paving the way to make us our own organ donors, reducing organ rejection and solve the problem with lack of donors. We can save lives with faster and more accurate methods for ...
The high-throughput, fully automated biodispensing solution that leverages BIOPOD (bioprinting on demand) technology with pre-set and pre-validated protocols to bring the power of 3D cell biology to your ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker ...
based inLlanera, SPAIN
A 100% Spanish owned biotechnological company specialising in the design, development and manufacture of nano-systems for drug delivery applications. Our technology is focussed on applications in the field of medicine where we develop systems to ...
Exosomes are extracellular vesicles of natural origin that are produced by all cell types in the range of 40 to 160 nm. They have a key role in cell-to-cell communication and have been proved to be powerful tools in diagnosis and therapeutics. Their ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
Olinvacimab is an anti-angiogenic antibody that neutralizes the VEGF/VEGFR2 pathway, thus inhibiting tumor growth and ...
based inSeattle, WASHINGTON (USA)
As the pioneer in the field of spatial biology, NanoString enables scientists across the globe to envision molecular interactions in three dimensions with three different systems, the nCounter Analysis System, the GeoMx Digital Spatial Profiler ...
based inLakewood, NEW JERSEY (USA)
We are an ISO9001 Certified manufacturer of enzymes and biochemicals for life science research, primary and stem cell isolation, bioprocessing, biopharma, diagnostics and biotechnology applications. Backed by over 75 years of expertise, we maintain ...
Prepared by modification of the procedure of Spudich and Watt, J. Biol. Chem., 246, 4866 (1971). Purity checked by SDS-PAGE. A lyophilized powder. Store at ...
based inTampa, FLORIDA (USA)
Inspirata, Inc. helps patients fighting cancer, and the clinicians they trust, make every moment matter. Our comprehensive cancer informatics solutions bring together disparate data throughout the entire cancer care journey to drive informed ...
Digital pathology is more than simple image viewing and evaluation. Dynamyx™ streamlines case management by exploiting advances in image digitization and solution interoperability to ensure the accelerated return of patient ...
based inWellesley Hills, MASSACHUSETTS (USA)
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 50 countries, TargetMol has evolved into one of ...